However, mutations in the PI3K–AKT–mTOR pathway are frequently observed in ovarian cancer, with evidence that this signaling pathway plays a prominent role in ovarian tumorigenesis and chemo- and radiotherapy resistance (30). This evidence concerns the gene PIK3CD and ovarian cancer.